April 29, 2021 — The results of a large, national heart attack study show that patients with cardiogenic shock...
Henry Ford Hospital
This page highlights news and new technology from Henry Ford Hospital in Detroit, Michigan. The hospital is a luminary center and also a pioneer of new cardiovascular technologies and techniques in the areas of complex PCI, including chronic total occlusions (CTO) and transcatheter structural heart treatments, including transcatheter valve replacement (TAVR), transcatheter LAA occlusion and MitraClip mitral valve repair. The center has also been at the forefront of how to improve mortality in cardiogenic shock patients and heads the National Cardiogenic Shock Initiative.
-
-
The resounding success of transcatheter aortic valve replacement (TAVR) has led the creation of hundreds of structural heart programs across the country in recent years.
-
Cardiologist William O’Neill, M.D., medical director of the Center for Structural Heart Disease at...
-
Detroit, Michigan, has been one the hardest hit regions with a large number of COVID-19 cases.
The Abiomed Impella percutaneous heart pump was shown in the NCSI study to greatly improve survival of acute myocardial infarction with cardiogenic shock (AMICS), raising survival from 50 percent to 71 percent. Ambulance image from Getty Images.
Feature | Cardiogenic Shock | April 29, 2021 | By Dave Fornell, Editor
April 29, 2021 — The results of a large, national heart attack study show that patients with cardiogenic shock...
Transesophageal echo (TEE) being used to guide the deployment of a MitraClip device during a structural heart procedure at the University of Colorado Hospital. The center has performed more than 200 MitraClip mitral valve repairs over the past decade. Photo by Dave Fornell
Feature | Structural Heart | April 22, 2021
The resounding success of transcatheter aortic valve replacement (TAVR) has led the creation of hundreds of structural...
Videos | Coronavirus (COVID-19) | April 10, 2020
Cardiologist William O’Neill, M.D., medical director of the Center for Structural Heart Disease at Henry Ford Hospital...
Videos | Coronavirus (COVID-19) | April 10, 2020
Detroit, Michigan, has been one the hardest hit regions with a large number of COVID-19 cases. William O’Neill, M.D.,...
Feature | Coronavirus (COVID-19) | April 10, 2020
April 10, 2020 — Enrollment began April 9 at Henry Ford Hospital for the first large-scale study in the United States...
360 Photos | 360 View Photos | October 08, 2019
Henry Ford Hospital in Detroit gets a lot of referrals for very sick patients seeking a last resort treatment in its...
Khaldoon Alaswad, M.D., right, director, cardiac catheterization lab, during a complex CTO procedure at Henry Ford Hospital. (Photo by Dave Fornell)
Feature | Henry Ford Hospital | October 01, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the cardiology conferences about new research and technology...
Videos | Cardiovascular Business | September 30, 2019
A discussion with Ruth Fisher, MBA, vice president of the Henry Ford Hospital structural heart program, and Janet Wyman...
Videos | Heart Valve Technology | September 30, 2019
Marvin Eng, M.D., structural fellowship director at Henry Ford Health System, and William O'Neill, M.D., director of...
Videos | Structural Heart | September 30, 2019
A discussion with William O’Neill, M.D., director of the Henry Ford structural heart program, Ruth Fisher, MBA, vice...
Videos | Cath Lab | September 28, 2019
A discussion with Nicolas Bevins, Ph.D., vice chair, physics and research, and Jessica Harrington, RCIS. They explain...
Videos | Hemodynamic Support Devices | September 22, 2019
There was a 77 percent increase in survival in cardiogenic shock patients treated using a new protocol in the National...
Videos | Chronic Total Occlusion (CTO) | September 28, 2019
A discussion with Khaldoon Alaswad, M.D., director, cardiac catheterization lab, Henry Ford Hospital, on treating...
Videos | Hemodynamic Support Devices | September 12, 2019
A discussion with William O'Neill, M.D., director of the structural heart program, Henry Ford Hospital, and Michele...
This image shows a left-ventricular outflow tract (LVOT) obstructed by an Edwards Sapien TAVR valve used for a valve-in-valve procedure. The arrow points to the small, crescent shaped dark area of the neo-LVOT, which did not allow enough blood to flow from the left ventricle into the aorta and the rest of the body. To prevent this issue, the procedure used by Henry Ford ablates (kills) some of the tissue in the cardiac septum to allow these valves to fit better and allow for an enlarged neo-LVOT for patients who otherwise could not receive this therapy.
News | Heart Valve Technology | July 03, 2019
July 3, 2019 — A study of a procedure developed at Henry Ford Health System shows inducing a heart attack in patients...
